Full Press Release Details
Lexaria and ViPovaTM Holiday SALE
Kelowna, BC November 25, 2015 - Lexaria Corp.
(LXRP-OTCQB) (LXX-CSE) (the "Company" or "Lexaria") announces its
first-ever Holiday blowout sale, just in time for the busiest shopping days of
The Holiday sale is effective immediately: all
ViPovaTM and Lexaria food products are being packaged into special
holiday bundles, and being made available at tremendous discounts of up to 53%
Holiday gift bundles start at just $15 and progress into larger
packages to fit any budget. Different collections of ViPovaTM Tea in
7 delicious flavors, the new ViPovaTM Columbian Coffee; rich and
soothing Hot Chocolate, and the Lexaria Protein Bars are all available and on
sale with special holiday discounts. Pick your flavors of tea and protein bars
Customers can browse the special gift packages available at
both www.vipova.com and at www.lexariaenergyfoods.com.
Please NOTE: ALL Holiday Bundle orders MUST BE PLACED BY
TELEPHONE ONLY at 1-888-976-8482 from 6AM to 4PM Pacific. You can also leave a
message at any time and a customer service representative will call you back
during these hours; or can leave your contact information at either
https://www.lexariaenergyfoods.com/contact/ and we will call you back to
All the food products incorporate Lexaria s patent-pending
technology to infuse full spectrum hemp oil into the foods for higher
absorption. All orders over $75 also qualify for free shipping within the
continental US, and the sale runs from all the way until close of business,
Lexaria is a food sciences company, with common shares quoted
in the USA with symbol LXRP and in Canada with symbol LXX. The company searches
for projects that could provide potential above-market returns.
To learn more about Lexaria Corp. visit www.lexariaenergy.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements
which are not historical facts are forward-looking statements. The Company makes
forward-looking public statements concerning its expected future financial
position, results of operations, cash flows, financing plans, business strategy,
products and services, competitive positions, growth opportunities, plans and
objectives of management for future operations, including statements that
include words such as "anticipate," "if," "believe," "plan," "estimate,"
"expect," "intend," "may," "could," "should," "will," and other similar
expressions are forward-looking statements, including but not limited to:
achieving sales through any retail distribution channels such as dispensaries or
traditional retailers. Such forward-looking statements are estimates reflecting
the Company's best judgment based upon current information and involve a number
of risks and uncertainties, and there can be no assurance that other factors
will not affect the accuracy of such forward-looking statements. Access to
capital, or lack thereof, is a major risk and there is no assurance that the
Company will be able to raise required working capital. Factors which could
cause actual results to differ materially from those estimated by the Company
include, but are not limited to, government regulation, managing and maintaining
growth, the effect of adverse publicity, litigation, competition, the patent
application and approval process and other factors which may be identified from
time to time in the Company's public announcements and filings. There is no
assurance that the medical marijuana, hemp oil sector, or alternative health
businesses will provide any benefit to Lexaria, or that the Company will
experience any growth through participation in these sectors. There is no
assurance that existing capital is sufficient for the Company's needs or that it
will not need to attempt to raise additional capital. There is no assurance that
any planned corporate activity, business venture, or initiative will be pursued,
or if pursued, will be successful. There is no assurance that any hemp oil or
cannabinoid-based product will promote, assist, or maintain any beneficial human
health conditions whatsoever. There is no assurance that the cannabinoid/lipid
infusion technology will provide any increase in bioavailability to any
individual person. There is no assurance that any patent application in the USA
or any other nation or under any treaty will result in the award of an actual
patent; nor that an award of any actual patent will protect against challenges
from unknown third parties. There is no assurance that any of Lexaria s
postulated uses, benefits, or advantages for the patent-pending technology will
in fact be realized in any manner or in any part. No statement herein has been
evaluated by the Food and Drug Administration (FDA). ViPovaTM
products and Lexaria Energy products are not intended to diagnose, treat, cure
or prevent any disease.
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.